AFP and hepatocellular carcinoma: The detection of Notch receptors as well as downstream targets in exosomes enriched with specific HCC proteins, including α-fetoprotein (AFP) and asialoglycoprotein receptor 1 (ASGPR1), could guide the identification of patients eligible for combined treatments with immune checkpoint inhibitors.